Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Hao Jiang's publication output changed over time?
ScholarIQpublication output · 2003–2025
Output grew0% over the shown period — from 1 works in 2003 to 1 in 2025.
1
2
1
2
1
1
1
1
1
200320052008200920112014201520172025
What are the most-cited papers on Hao Jiang?
ScholarIQmost cited works
Squaramides: Bridging from Molecular Recognition to Bifunctional Organocatalysis
José Alemán, Alejandro Parra, Hao Jiang, Karl Anker Jørgensen
S68911691. 2011694 Citations
Resveratrol downregulates PI3K/Akt/mTOR signaling pathways in human U251 glioma cells.
Hao Jiang, Xia Shang, Hongtao Wu, Subhash C. Gautam, Shaza N. Al‐Holou, Christina Li, Jarret Kuo, Lijie Zhang, Michael Chopp
PubMed. 2009154 CitationsOPEN ACCESS
Resveratrol-induced apoptotic death in human U251 glioma cells
Hao Jiang, Lijie Zhang, Jarret Kuo, Kelly Kuo, Subhash C. Gautam, Laurent Groc, Alba I. Rodríguez, David Koubi, Tangella Jackson Hunter, George B. Corcoran, Michael D. Seidman, Robert A. Levine
S48437117. 2005136 Citations
New GO–PEI–Au– <scp>l</scp> -Cys ZIC-HILIC composites: synthesis and selective enrichment of glycopeptides
Bo Jiang, Yu Liang, Qi Wu, Hao Jiang, Kaiguang Yang, Lihua Zhang, Zhen Liang, Xiaojun Peng, Yukui Zhang
S23181512. 2014102 Citations
Resveratrol inhibits glioma cell growth via targeting oncogenic microRNAs and multiple signaling pathways
Guangxiu Wang, Fang Dai, Kai Yu, Zhifan Jia, Anling Zhang, Qiang Huang, Chunsheng Kang, Hao Jiang, Peiyu Pu
S4210208883. 201592 CitationsOPEN ACCESS
Related on ScholarIQ
Beijing Institute of Technology
Institution
Squaramides: Bridging from Molecular Recognition to Bifunctional Organocatalysis
Paper
Resveratrol downregulates PI3K/Akt/mTOR signaling pathways in human U251 glioma cells.
Paper
Resveratrol-induced apoptotic death in human U251 glioma cells
Paper
New GO–PEI–Au– <scp>l</scp> -Cys ZIC-HILIC composites: synthesis and selective enrichment of glycopeptides
Paper
Resveratrol inhibits glioma cell growth via targeting oncogenic microRNAs and multiple signaling pathways
Paper